Agilent TechnologiesandImperial College London have signed a strategic scientific collaboration agreement that brings together Agilent’s analytical technologies with Imperial researchers
Two reports published in Biological Psychiatry demonstrate an approach to use electronic health records to more accurately investigate neuropsychiatric symptoms.
Researchers at Earlham Institute (EI) have released ‘GeneSeqToFamily’, an open-source Galaxy workflow that helps scientists to find gene families based on the ‘EnsemblCompara GeneTrees’ pipeline.
DNAnexus has announced a software solution which focuses on next-generation sequencing (NGS) driven adaptive trial design to optimise and reduce the risk of clinical trials
The Pistoia Alliance, has announced the launch of the User Experience for Life Sciences (UXLS) Toolkit - to help life science companies improve user experience in line with other global industries
This year the Paperless Lab Academy (#PLA2018) conference will move to a new location overlooking Lake Maggiore on the southern side of the Alps, near Milan, Italy. The central theme will focus on how to ‘Empower your eData Life Cycle.’
Optalysys, a start-up commercialising optical coprocessors for AI/deep learning, and genomic research institute The Earlham Institute (EI) have announced the completion of the Genetic Search System (GENESYS) project
Optibrium, a developer of software for small molecule drug discovery, today announced it has appointed Dr Scott Lyon as director of business development and relocated its Headquarters and research facilities, to Cambridge Innovation Park, Cambridge, UK
Qlucore and Nebion have started a collaboration to provide scientists with an end-to-end solution for gene expression analysis, by combining Qlucore Omics Explorer and Genevestigator into a single end to end software package
Research carried out Barcelona Supercomputing Center (BSC) which reanalysed public genetic data using innovative computational methods has enabled the identification of new genetic markers associated with an increased risk to develop Type 2 Diabetes (T2D)
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
